If the involved journals were obliged to publish corrigenda, it would encourage scientists to seek answers to the important question as to why elevated levels of 17β-HSD10 besides Aβ and phosphorylated Tau are present in the brains of AD patients and mouse AD models. Here, MAPT is linked to Alzheimer disease.